A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy  MSCs and a plasmapheresis device  24  Administered through integration into a Continuous Renal Replacement Therapy circuit  Phase 2   94